This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

Bristol Myers Squibb-AstraZeneca EEIG

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH, UK
Telephone: +44(0)1895 523000
Fax: +44(0)1895523010
E-mail: medical.information@bms.com
Medical Information Direct Line: +44(0)8007311736
Medical Information Fax: +44(0)1895523677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Patient Information Leaflet last updated on the eMC: 20/12/2013
PIL Forxiga 5 mg & 10 mg film coated tablets
black triangle icon
Black Triangle:

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.


The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged. This PIL is in PDF format.

View Patient Information Leaflet (0.254MB)

Are you having problems reading or printing this PDF? Visit adobe.com and download the Adobe Acrobat Reader.


More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/27191/XPIL/


Active Ingredients/Generics